About

CLP excludes from its scope in vitro diagnostic medical devices (IVDs) in finished form (Article 1(5)(d)). Does this mean that a hazard label according to CLP doesn’t have to be prepared for a product registered as IVD? Not exactly. The sector legislation (Directive 98/79/EC, replaced by Regulation (EU) 2017/746 from May 2022), provides that CLP labelling requirements fully apply and only in special cases hazard label elements can be omitted....
more

Regulation (EU) 2020/878 updated REACH Annex II, which sets the requirements for the compilation of the Safety Data Sheets (SDS) within EEA. The main purpose of the update was to include in the SDS information on nanomaterials and on hazards related to endocrine disrupting properties, as well as to implement the requirements of the latest GHS version into the EU legislation. Newly prepared SDS have to comply with the regulation starting January 2021. SDS prepared before January 2021 have to be updated by 2023. ...
more

According to Art 9(1)(i) of the Directive 2008/98/EC (Waste Framework Directive), starting 5 January 2021 articles containing SVHC above 01,%w/w need to be notified to the ECHA SCIP database before they are placed on the market. The SCIP notification needs to be done by all actors placing such articles on the market e.g. EU producers or assemblers, EU importers and EU distributors. For importers it is difficult to collect the necessary information....
more